CERIANNA

This brand name is authorized in United States.

Active ingredients

The drug CERIANNA contains one active pharmaceutical ingredient (API):

`1`	Fluoroestradiol ¹⁸F UNII `T32277KB09` - FLUOROESTRADIOL F-18
	Fluoroestradiol ¹⁸F binds estrogen receptor (ER) and is indicated for use with positron emission tomography (PET imaging) for characterization of ER status of known or suspected metastatic lesions in patients with confirmed ER-positive breast cancer.
	Read more about Fluoroestradiol ¹⁸F

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CERIANNA Solution for injection	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
US	FDA, National Drug Code	72874-001

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.